Literature DB >> 17917015

TACI, isotype switching, CVID and IgAD.

Emanuela Castigli1, Raif S Geha.   

Abstract

Common Variable Immunodeficiency (CVID) is the most prevalent human primary immunodeficiency requiring medical attention. Until recently the only known genetic defect specific to CVID was ICOS deficiency that accounts for about 1% of the patients analyzed. Mutations in the TNFR family member TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor), which mediates isotype switching in B cells, were found to be present in 5% of patients with CVID. Mutations in TACI were also found in relatives of patients with CVID who suffered from IgA deficiency (IgAD) as well as in a patient with isolated IgAD. In the majority of patients described to date only one TACI allele is mutated, showing an autosomal dominant transmission of the disease. B cells from individuals with TACI mutations did not produce IgG and IgA in response to the TACI ligand, APRIL (a proliferation-inducing ligand), probably reflecting impaired isotype switching. These results suggest that TACI mutations can lead to CVID.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917015     DOI: 10.1007/s12026-007-8000-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  52 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

Review 3.  Common variable immunodeficiency: a review.

Authors:  M Di Renzo; A L Pasqui; A Auteri
Journal:  Clin Exp Med       Date:  2004-04       Impact factor: 3.984

4.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

Authors:  G U von Bülow; R J Bram
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 5.  IgA deficiency.

Authors:  P D Burrows; M D Cooper
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

6.  Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.

Authors:  Chao-Zhou Ni; Gagik Oganesyan; Kate Welsh; Xiuwen Zhu; John C Reed; Arnold C Satterthwait; Genhong Cheng; Kathryn R Ely
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

7.  Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency.

Authors:  Klaus Warnatz; Lukas Bossaller; Ulrich Salzer; Andrea Skrabl-Baumgartner; Wolfgang Schwinger; Mirjam van der Burg; Jacques J M van Dongen; Marzena Orlowska-Volk; Rolf Knoth; Anne Durandy; Ruth Draeger; Michael Schlesier; Hans Hartmut Peter; Bodo Grimbacher
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

Review 8.  TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.

Authors:  Ulrich Salzer; Bodo Grimbacher
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

9.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  8 in total

1.  The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency.

Authors:  Jeremy M Woodward; Effrossyni Gkrania-Klotsas; Anthony Yk Cordero-Ng; Aloysious Aravinthan; Betty N Bandoh; Hongxiang Liu; Susan Davies; Hongyi Zhang; Philip Stevenson; Martin D Curran; Dinakantha Kumararatne
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

2.  Common variable immunodeficiency.

Authors:  Jonathan S Tam; John M Routes
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

Review 3.  Innate control of B cell responses.

Authors:  Andrea Cerutti; Irene Puga; Montserrat Cols
Journal:  Trends Immunol       Date:  2011-03-16       Impact factor: 16.687

4.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 6.  Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.

Authors:  Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06       Impact factor: 10.793

Review 7.  Peyer's patches: organizing B-cell responses at the intestinal frontier.

Authors:  Andrea Reboldi; Jason G Cyster
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

8.  TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA.

Authors:  Jeffrey L Platt; Mayara Garcia de Mattos Barbosa; Daniel Huynh; Adam R Lefferts; Juhi Katta; Cyra Kharas; Peter Freddolino; Christine M Bassis; Christiane Wobus; Raif Geha; Richard Bram; Gabriel Nunez; Nobuhiko Kamada; Marilia Cascalho
Journal:  JCI Insight       Date:  2021-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.